Snapshot from Jun 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Roche

United States — Food and Drug Administration & Roche

1 shared events · Importance 3 · Last updated Jun 13, 2026

Importance
3
Shared Events
1
Actions
1
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
95
Regulatory
Roche FDA Approves PTEN Assay
United States — Food and Drug Administration: The United States — Food and Drug Administration approved the VENTANA PTEN (SP218) RxDx Assay, enabling its use as a companion diagnostic for prostate cancer treatment.
Roche: Roche received FDA approval for its VENTANA PTEN (SP218) RxDx Assay, reinforcing its leadership in companion diagnostics and expanding personalized healthcare options for prostate cancer patients.
Jun 12, 2026 · 6 articles
Actions (1)
100 United States — Food and Drug Administration approved assay RocheRoche FDA Approves PTEN Assay
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and Roche interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.